Search

Search Constraints

You searched for: Author/Creator Lirio, Richard A.

Search Results

1. Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Potential in Patients With Inflammatory Bowel Diseases. Issue 7 (16th December 2020)

2. Early Clinical Response and Remission With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From VARSITY: 716. (October 2019)

3. Histologic Improvement With Vedolizumab vs. Adalimumab in Ulcerative Colitis: Results From VARSITY: 757. (October 2019)

4. Long‐term safety of vedolizumab for inflammatory bowel disease. Issue 8 (2nd September 2020)

5. NASPGHAN Capsule Endoscopy Clinical Report. Issue 3 (March 2017)

6. S0664 Disease Control and Changes in Individual Treatment Outcomes From Week 14 to Week 52 With Vedolizumab or Adalimumab in Ulcerative Colitis: A VARSITY Trial Post Hoc Analysis. (October 2020)

7. S0876 Assessment of Vedolizumab Disease-Drug-Drug Interaction in Patients With Inflammatory Bowel Diseases. (October 2020)